| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |